Global Self-injections Market By Type (Devices, Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), Route of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), End User (Patient, Physicians, Home Care Settings, Others), Distribution Channel (Hospital Pharmacies, Private Clinics, Chemist, Online Pharmacies), – Industry Trends and Forecast to 2029
Market Analysis and Size
Self-injections are becoming a popular method of administering drug therapies at home. Self-inject medication, for example, is commonly used by insulin-dependent diabetics and people suffering from arthritis because it is a simple and dependable way to self-administer drugs.
Data Bridge Market Research analyses that the self-injections market is expected to reach the value of USD 298.34 billion by the year 2029, at a CAGR of 23.2% during the forecast period.
Market Definition
Self-injections are an appealing option for administering drug therapies in one's own home. It is a simple and dependable way for insulin-dependent diabetics and arthritis patients to self-administer medications.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
By Type (Devices, Formulations), Dosage Form (Single Dose, Multi-Dose), Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Others), Route of Administration (Skin, Circulatory/Musculoskeletal, Organs, Central Nervous System), End User (Patient, Physicians, Home Care Settings, Others), Distribution Channel (Hospital Pharmacies, Private Clinics, Chemist, Online Pharmacies)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
Market Players Covered
|
Bristol-Myers Squibb Company (Canada), Scintilla Pharmaceuticals, Inc. (U.S), Flexion Therapeutics Inc. (U.S), Pfizer Inc. (U.S), Mylan N.V. (U.S), EIPICO (Egypt), Advanz Pharma (U.K), Intrapharm Laboratories (U.K), Flagship (India), Health Biotech Limited (India), Merck & Co., Inc. (U.S), Bayer AG (Germany), GSK Group of Companies (U.K), Sumitomo Pharma Co., Ltd. (Japan), AstraZeneca (U.K), Cipla Inc. (India), Novartis AG (Switzerland)
|
Opportunities
|
|
|
|
Self-injections Market Dynamics
Drivers
- The rise in the awareness of the benefits among population
The numerous benefits and wonderful features of self-injection are among the important factors driving the growth and demand for self-injections. Furthermore, the growing number of chronic disease patients and diabetic patients are contributing to the global market's growth
The increase in the per capita spending
The rapid increase in spending per capita income, as well as technological advancement and innovation, are also boosting market growth. Furthermore, rising diabetes incidence rates and higher disposable income are important factors driving the growth of the self-injections market. Removing the need to visit a clinic or hospital for regular injections will also ensure strong industry growth during the forecast period.
Regulatory Compliance
Maintaining compliance with medical reforms and regulations raises the demand for these solutions.
- Government investments for healthcare interoperability
In the forecast period, the development of biologic drugs to treat autoimmune disease, rising demand for self-injection devices, and increased health consciousness will provide significant growth opportunities for the market.
.Restraints/Challenges
The high cost of development, lack of awareness of such devices, and stringent regulatory framework for approval from regulatory authorities will limit the growth of the self-injections market, whereas injection sterility has the potential to challenge the growth of the self-injections market.
This self-injections market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the self-injections market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Self-injections Market
Most industries around the world have been negatively impacted in recent months. This is due to significant disruptions in their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns and other restrictions imposed by governing authorities around the world. The same is true for the global market for Self-injection Devices. Furthermore, consumer demand has subsequently decreased as people are now more focused on eliminating non-essential expenses from their respective budgets as the general economic status of most people has been severely impacted by this outbreak. These factors are expected to weigh on the revenue trajectory of the global Self-injection Device market over the forecast period.
Global Self-injections Market Scope
The self-injections market is segmented on the basis type, dosage form, and therapeutic application, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Devices
- Formulations
On the basis of type, the self-injections market is segmented into devices and formulations. Devices have further been segmented into needle-free injectors, auto injectors, pen injectors and wearable injectors.
Dosage
- Single dose
- Multi dose
The self-injections market is also segmented on the basis of dosage form into single dose and multi-dose.
Application
- Autoimmune diseases
- Hormonal disorders
- Oncology
- Orphan diseases
- Pain management
- Respiratory therapy
- Others
Based on therapeutic application, the self-injections market is segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy and others.
Route of administration
- Skin
- Circulatory/musculoskeletal
- Organs
- Central nervous system
The self-injections market is segmented on the basis of route of administration into skin, circulatory/musculoskeletal, organs and central nervous system.
End user
- Patient
- Physicians
- Home care settings
- Others
The end user segment of self-injections market is segmented into patient, physicians, home care settings and others.
Distribution channel
- Hospitals pharmacies
- Clinics
- Chemist
- Online pharmacies
Based on distribution channel, the self-injections market is segmented into hospital pharmacies, private clinics, chemist and online pharmacies.
Self-injections Market Regional Analysis/Insights
The self-injections market is analysed and market size insights and trends are provided by country, type, dosage form, and therapeutic application, route of administration, end user and distribution channel as referenced above.
The countries covered in the self-injections market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the self-injections market due to the appropriate healthcare organisation, which simplifies easy access to innovative self-injections. Furthermore, increasing government initiatives, combined with a well-planned repayment scenario, will drive the growth of the self-injections market in the region during the forecast period. Because of the research and development funds available to create technologically innovative healthcare treatment options, Asia Pacific is expected to see significant growth in the self-injections market. Furthermore, the existence of various trade agreements is expected to propel the growth of the self-injections market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The self-injections market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for self-injections market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the self-injections market. The data is available for historic period 2010-2020.
Competitive Landscape and Self-injections Market Share Analysis
The self-injections market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to self-injections market.
Some of the major players operating in the self-injections market are
- Bristol-Myers Squibb Company (Canada)
- Scintilla Pharmaceuticals, Inc. (U.S)
- Flexion Therapeutics Inc. (U.S)
- Pfizer Inc. (U.S)
- Mylan N.V. (U.S)
- EIPICO (Egypt)
- Advanz Pharma (U.K)
- Intrapharm Laboratories (U.K)
- Flagship (India)
- Health Biotech Limited (India)
- Merck & Co., Inc. (U.S)
- Bayer AG (Germany)
- GSK Group of Companies (U.K)
- Sumitomo Pharma Co., Ltd. (Japan)
- AstraZeneca (U.K)
- Cipla Inc. (India)
- Novartis AG (Switzerland)
SKU-